Clinical Trial Update: A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period [NA]

View source ↗

Summary

A completed clinical trial studying the disease behavior of idiopathic pulmonary fibrosis and interstitial lung disease during the peri-diagnostic period; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | NA | Status: COMPLETED | Results posted: 2021-03-26